AI helps you reading Science
AI generates interpretation videos
AI extracts and analyses the key points of the paper to generate videos automatically
AI parses the academic lineage of this thesis
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
The Lancet Oncology, no. 3 (2009): 223-232
Background Drug treatments for patients with high-risk myelodysplastic syndromes provide no survival advantage. In this trial, we aimed to assess the effect of azacitidine on overall survival compared with the three commonest conventional care regimens. Methods In a phase III, international, multicentre, controlled, parallel-group, open-l...More
PPT (Upload PPT)